The Patent Finder
US

2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors

US 8,450,335 In force
OverviewFamilyAssignmentsSources & methods

Term ends Feb 13, 2030 · High confidence

Filed Jun 26, 2009 as application 12/492,180 · Granted May 28, 2013
Base term plus 232 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2009 2030
Clock starts
Jun 26, 2009
Term ends
Feb 13, 2030
Granted
May 28, 2013
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
232
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 232 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 26, 2009, when this application, 12/492,180, was filedJun 26, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+232 days, USPTO patent term adjustment recordFeb 13, 2030High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderFeb 13, 2030High confidence

This family

US 8,450,335this patent
Feb 2030
Feb 2030
US 8,338,439In force
Sep 2029
Sep 2029
US 8,710,222In force
Jun 2029
Jun 2029
US 9,296,737In force
Jun 2029
Jun 2029
US 8,609,679In force
Jun 2029
Jun 2029
US 9,212,181In force
Jun 2029
Jun 2029
US 9,409,921In force
Nov 2029
Nov 2029
US 9,987,276In force
Jun 2029
Jun 2029
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 10, 2009
Reel 23213, frame 268
Singh, Juswinder; Petter, Russell; Tester, Richland Wayne; Kluge, Arthur F.; Mazdiyasni, Hormoz; Westlin, William Frederick, III; Niu, Deqiang; Qiao, LixinAvila Therapeutics, Inc.Assignment of Assignor's Interest
Sep 28, 2012
Reel 29058, frame 66
Avila Therapeutics, Inc.Celgene Avilomics Research, Inc.Change of Name
Feb 16, 2017
Reel 41738, frame 41
Celgene Avilomics Research, Inc.; Celgene Car LLCCelgene Car LLCMerger and Change of Name
May 3, 2023
Reel 63526, frame 959
Celgene Car LLCBristol-Myers Squibb CompanyNunc Pro Tunc Assignment

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited